Status:
COMPLETED
The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Vitamin C Deficiency
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
To evaluate the difference between vitamin C in the form of oral liposomes and general vitamin C in a fixed period of time in plasma and urine.
Detailed Description
we recruited 11 healthy subjects and adopted a cross-over test. the subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next ...
Eligibility Criteria
Inclusion
- Adults between 20-60 years old,
- No heart, liver, kidney, endocrine and major organic diseases
Exclusion
- Renal insufficiency and dialysis
- Cancer
- Underweight (BMI≦17) or obese (BMI≧27),
- Take chronic disease drugs,
- Blood pressure systolic blood pressure ≧130 mmHg or diastolic blood pressure ≧85 mmHg,
- Too high fasting blood glucose ≧ 100 mg/dL,
- Triglyceride ≧ 150 mg/dL,Total cholesterol ≧ 200 mg/dL,
- Have a history of vitamin C allergy,
- People with mental illness,
- Pregnant or breastfeeding women,
- Hematosis,
- Kidney stones,
- Long-term vitamin C supplements (at least 200 mg per day for more than one month)
Key Trial Info
Start Date :
June 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04886752
Start Date
June 10 2019
End Date
December 31 2020
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research & Design Center, TCI CO., Ltd
Taipei, Taiwan, 114